IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy
IBA has entered into a sponsored research agreement with The University of…
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
NIH research clears way for study of experimental treatment for opioid use disorder
The National Institutes of Health (NIH) today announced that its Investigational New…
Century Health Raises $5M Seed Round as AI-Powered Platform Achieves 97% Accuracy in Clinical Data Abstraction
Century Health has raised an oversubscribed $5 million seed round to expand…
KFSH Tops Saudi Healthcare Sector in Nature Index 2025
King Faisal Specialist Hospital and Research Centre ranked first among Saudi healthcare…
Dubai Health and DNDi Sign MoU to Combat Neglected Diseases
Dubai Health and the Drugs for Neglected Diseases initiative (DNDi) have signed…
QU Advances Pharmacogenomics and Precision Medicine Research
Qatar University is leading a pioneering pharmacogenomics and AI-driven precision medicine study…
Eko Health Appoints Dr. Steven Steinhubl as Chief Medical Officer
Eko Health has appointed Steven R. Steinhubl as Chief Medical Officer to…
First locally discovered drug candidate: UAE joins AI-powered drug development race
The UAE has announced its first fully AI-discovered drug candidate, ISM0387, developed…
